Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insight into Essential and Complex Autism Spectrum Disorders: Clinical Characteristics, Chromosomal Microarray Analysis, and Risk Factors. | Genes (Basel) | 2026 | 42792940 | PubTator, text mining | PubMed |
| BUB1 and CDK4/6 Dual Inhibition Increases Radiation Sensitivity in Glioblastoma, Lung Cancer, and Triple-Negative Breast Cancer. | Biomedicines | 2026 | 42792682 | PubTator, text mining | PubMed |
| Immune cell enrichment characteristics and related key genes in intrauterine adhesion: insights from RNA-sequencing analysis. | Syst Biol Reprod Med | 2026 | 42763899 | PubTator, text mining | PubMed |
| Real-world insights into genomic reprogramming during CAR-T cell manufacturing in India. | Front Immunol | 2026 | 42756106 | PubTator, text mining | PubMed |
| System level identification and multidimensional analysis of hub genes reveal complex regulatory networks underlying human iPSC differentiation into motor neurons. | Biochem Biophys Rep | 2026 | 42630798 | PubTator, text mining | PubMed |
| BUB1 regulates cell proliferation and apoptosis in cervical cancer by AKT signaling and autophagosome-lysosome fusion via ACTN1. | iScience | 2026 | 42602342 | PubTator, text mining | PubMed |
| Transcriptomic differences in chromatin and cell cycle regulation in A549 cells after irradiation with carbon ions and X-rays. | Front Oncol | 2026 | 42524029 | PubTator, text mining | PubMed |
| Epilepsy and Intellectual Disability in a Boy with a 2q13 Microdeletion Affecting the BUB1 Gene. | Pediatr Rep | 2026 | 42496474 | PubTator, text mining | PubMed |
| Unveiling immune-related gene signatures in triple negative breast cancer through integrated transcriptomic analysis. | Biomedicine (Taipei) | 2026 | 42483440 | PubTator, text mining | PubMed |
| Transcriptomics-driven non-invasive liquid biopsy for diagnosing peritoneal lavage cytology-positive gastric cancer. | NPJ Precis Oncol | 2026 | 42457866 | PubTator, text mining | PubMed |
| Identification and validation of novel candidate genes with diagnostic value for sepsis via weighted gene co-expression network analysis. | Front Med (Lausanne) | 2026 | 42445139 | PubTator, text mining | PubMed |
| Exploring the potential involvement of UFSP2 in spindle assembly checkpoint regulation in breast cancer. | Mol Biol Rep | 2026 | 42430000 | PubTator, text mining | PubMed |
| Identification of genes differentially expressed in granulosa cells from women with high vs. low ovarian responsiveness. | Front Reprod Health | 2026 | 42358728 | PubTator, text mining | PubMed |
| BUB1 in cancer genetics and oncogenomics: from chromosomal instability to therapeutic vulnerabilities. | Front Genet | 2026 | 42338979 | PubTator, text mining | PubMed |
| hSpindly dynamics modulate spindle assembly checkpoint signaling, promoting resistance to mitotic inhibitors. | iScience | 2026 | 42338480 | PubTator, text mining | PubMed |
| Response of MRC-5 human lung fibroblasts to FLASH and conventional radiotherapy: A study on differential DNA damage and transcriptomic response. | Comput Biol Chem | 2026 | 42314223 | PubTator, text mining | PubMed |
| BUB1B is a novel prognostic-related biomarker and correlated with immune infiltrates in lung adenocarcinoma. | Clin Transl Oncol | 2026 | 42295646 | PubTator, text mining | PubMed |
| Integrative in-silico analysis on phytocompounds of Pajanelia longifolia against hepatocellular carcinoma: gene network target identification, molecular docking, simulation and ADMET profiling. | In Silico Pharmacol | 2026 | 42211827 | PubTator, text mining | PubMed |
| Identification and preliminary clinical validation of type 2 diabetes signature genes through machine learning analysis of scRNA-seq data. | Front Med (Lausanne) | 2026 | 42205842 | PubTator, text mining | PubMed |
| TTK Overexpression as a Prognostic Indicator and Immune Modulator in Kidney Renal Clear Cell Carcinoma. | Mol Carcinog | 2026 | 42189826 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers